Phenotype
|
Fish
|
Conditions
|
Figures
|
pronephros lacks all parts of type corpuscles of Stannius, abnormal
|
TU + MO1-sim1a + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephric proximal convoluted tubule distended, abnormal
|
TU + MO1-sim1a + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephros lacks all parts of type pronephric proximal straight tubule, abnormal
|
TU + MO1-sim1a + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephric proximal tubule development decreased process quality, abnormal
|
TU + MO1-sim1a + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephric distal early tubule mislocalised posteriorly, abnormal
|
TU + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephric proximal convoluted tubule distended, abnormal
|
TU + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
pronephric proximal straight tubule mislocalised posteriorly, abnormal
|
TU + MO1-tp53
|
standard conditions
|
Fig. S6
from Cheng et al., 2015
|
retinal ganglion cell layer morphology, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
retinal ganglion cell decreased amount, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4,
Fig. 6
from Diekmann et al., 2009
|
eye mislocalised ventrally, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 3
from Diekmann et al., 2009
|
eye decreased size, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 3,
Fig. 4,
Fig. S2
from Diekmann et al., 2009
|
integument melanocyte decreased contractility, abnormal
|
WT + MO1-alcama + MO1-tp53
|
high light intensity
|
Fig. 3
from Diekmann et al., 2009
|
ventral mandibular arch decreased size, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 3
from Diekmann et al., 2009
|
integument melanocyte spatial pattern, abnormal
|
WT + MO1-alcama + MO1-tp53
|
high light intensity
|
Fig. 3
from Diekmann et al., 2009
|
retinal neural layer nucleus apoptotic, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
optic nerve head axon absent, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
pericardial cavity increased size, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 3
from Diekmann et al., 2009
|
retina morphogenesis in camera-type eye disrupted, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 6
from Diekmann et al., 2009
|
whole organism decreased size, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 3
from Diekmann et al., 2009
|
retinal inner nuclear layer neuron decreased amount, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
neuron differentiation arrested, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 6
from Diekmann et al., 2009
|
cranial nerve II aplastic, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 5
from Diekmann et al., 2009
|
neuron differentiation decreased rate, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 6
from Diekmann et al., 2009
|
cranial nerve II decreased thickness, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 5
from Diekmann et al., 2009
|
optic nerve head decreased size, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
eye decreased diameter, abnormal
|
WT + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 4
from Diekmann et al., 2009
|
forebrain apoptotic, abnormal
|
WT + MO1-appl1 + MO1-tp53
|
standard conditions
|
Fig. S4
from Schenck et al., 2008
|
neural crest cell migration disrupted, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
post-vent region decreased length, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2 ,
Fig. S1
from Tuttle et al., 2014
|
post-vent region curved, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S1
from Tuttle et al., 2014
|
melanocyte decreased amount, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S1
from Tuttle et al., 2014
|
post-vent region kinked, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
midbrain hindbrain boundary morphology, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
pericardium edematous, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S1
from Tuttle et al., 2014
|
xanthoblast neural crest cell aggregated, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
canonical Wnt signaling pathway decreased process quality, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 5
from Tuttle et al., 2014
|
melanoblast neural crest cell aggregated, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
neural crest cell migration decreased rate, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S5
from Tuttle et al., 2014
|
neural crest cell mislocalised, abnormal
|
WT + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-plrg1 + MO1-tp53
|
standard conditions
|
Fig. 9
from Kleinridders et al., 2009
|
whole organism apoptotic, abnormal
|
WT + MO1-plrg1 + MO1-tp53
|
standard conditions
|
Fig. 9
from Kleinridders et al., 2009
|
somite border muscle tendon junction morphology, abnormal
|
WT + MO1-thbs4b + MO1-tp53
|
mechanical stress
|
Fig. 2
from Subramanian et al., 2014
|
muscle detached from tendon, abnormal
|
WT + MO1-thbs4b + MO1-tp53
|
standard conditions
|
Fig. 4
from Subramanian et al., 2014
|
somite border muscle tendon junction morphology, abnormal
|
WT + MO1-thbs4b + MO1-tp53
|
standard conditions
|
Fig. 4 ,
Fig. 5
from Subramanian et al., 2014
|
muscle detached from tendon, abnormal
|
WT + MO1-thbs4b + MO1-tp53
|
mechanical stress
|
Fig. 2
from Subramanian et al., 2014
|
neural crest cell aggregated, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S2 ,
Fig. S3
from Tuttle et al., 2014
|
neural crest cell endosome immature, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3
from Tuttle et al., 2014
|
neural crest cell migration decreased rate, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
neural crest cell migration process quality, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2
from Tuttle et al., 2014
|
neural crest cell early endosome aggregated, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3
from Tuttle et al., 2014
|
neural crest cell late endosome decreased size, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3
from Tuttle et al., 2014
|
neural crest cell early endosome increased size, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3 ,
Fig. S6
from Tuttle et al., 2014
|
neural crest cell mislocalised, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. S2 ,
Fig. S3
from Tuttle et al., 2014
|
neural crest cell late endosome decreased amount, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3
from Tuttle et al., 2014
|
neural crest cell endocytosis process quality, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3
from Tuttle et al., 2014
|
neural crest cell early endosome increased amount, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 3 ,
Fig. S6
from Tuttle et al., 2014
|
neural crest cell migration disrupted, abnormal
|
ir937Tg + MO1-dmxl2 + MO1-tp53
|
standard conditions
|
Fig. 2 ,
Fig. S2 ,
Fig. S3
from Tuttle et al., 2014
|
neural crest cell early endosome increased amount, abnormal
|
ir937Tg + MO1-tp53 + MO2-atp6v0a1a
|
standard conditions
|
Fig. 4
from Tuttle et al., 2014
|
neural crest cell endosome immature, abnormal
|
ir937Tg + MO1-tp53 + MO2-atp6v0a1a
|
standard conditions
|
Fig. 4
from Tuttle et al., 2014
|
neural crest cell migration process quality, abnormal
|
ir937Tg + MO1-tp53 + MO2-atp6v0a1a
|
standard conditions
|
Fig. 4
from Tuttle et al., 2014
|
neural crest cell migration disrupted, abnormal
|
ir937Tg + MO1-tp53 + MO2-atp6v0a1a
|
standard conditions
|
Fig. 4
from Tuttle et al., 2014
|
neural crest cell migration decreased rate, abnormal
|
ir937Tg + MO1-tp53 + MO2-atp6v0a1a
|
standard conditions
|
Fig. 4
from Tuttle et al., 2014
|
neural crest cell aggregated, abnormal
|
ir937Tg + MO1-tp53 + MO2-dmxl2
|
standard conditions
|
Fig. S3
from Tuttle et al., 2014
|
neural crest cell migration disrupted, abnormal
|
ir937Tg + MO1-tp53 + MO2-dmxl2
|
standard conditions
|
Fig. S3
from Tuttle et al., 2014
|
neural crest cell mislocalised, abnormal
|
ir937Tg + MO1-tp53 + MO2-dmxl2
|
standard conditions
|
Fig. S3
from Tuttle et al., 2014
|
cranial nerve II aplastic, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
retinal rod cell differentiation process quality, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
retinal ganglion cell decreased amount, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
amacrine cell decreased amount, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
cranial nerve II decreased thickness, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
retina morphogenesis in camera-type eye disrupted, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
retinal rod cell differentiation delayed, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
neuron differentiation arrested, abnormal
|
s356tTg + MO1-alcama + MO1-tp53
|
standard conditions
|
Fig. 7
from Diekmann et al., 2009
|
muscle detached from tendon, abnormal
|
ilkhu801/hu801 + MO1-thbs4b + MO1-tp53
|
mechanical stress
|
Fig. 4
from Subramanian et al., 2014
|
median fin fold degeneration, ameliorated
|
mtm1zf711/zf711 + MO1-hdac1 + MO1-tp53
|
standard conditions
|
Fig. 1
from Volpatti et al., 2022
|
median fin fold degenerate, abnormal
|
mtm1zf711/zf711 + MO1-hdac3 + MO1-tp53
|
standard conditions
|
Fig. 1
from Volpatti et al., 2022
|
median fin fold degenerate, exacerbated
|
mtm1zf711/zf711 + MO1-hdac6 + MO1-tp53
|
standard conditions
|
Fig. 1
from Volpatti et al., 2022
|
median fin fold degenerate, exacerbated
|
mtm1zf711/zf711 + MO1-hdac8 + MO1-tp53
|
standard conditions
|
Fig. 1
from Volpatti et al., 2022
|
T cell differentiation in thymus disrupted, abnormal
|
top3at22406/t22406 + MO1-tp53 (TU)
|
standard conditions
|
Fig. 3
from Mönnich et al., 2010
|
pharyngeal arch 5 immature, abnormal
|
WT + MO1-rarga + MO1-rargb + MO1-tp53
|
standard conditions
|
Fig. 4
from Linville et al., 2009
|